Bedfont® Scientific Ltd.
From NObreathMay 20 2026 Bedfont® Scientific Ltd., an innovative leader in the medical breath analysis industry with almost 50 years of experience, is pleased to join thousands of healthcare experts at this year’s European Academy of Allergy and Clinical Immunology Congress 2026 at stand I03 to showcase its NObreath® and Gastrolyzer® range of non-invasive breath analysis devices.
Image Credit: Bedfont® Scientific Ltd. The congress, taking place in Istanbul, Türkiye from Friday 12th to Sunday 14th of June, is widely recognized as the world’s largest and most influential meeting dedicated to allergy and clinical immunology. It brings together thousands of clinicians, researchers and healthcare professionals from across the globe each year to share new ideas and showcase innovations in diagnostics, playing a central role in advancing research, education and patient care in allergic diseases such as asthma and food allergy.
Attending the EAACI Congress 2026 reflects our commitment to strengthening our global network. We look forward to connecting with like-minded organisations, sharing insights into our technology, and exploring new distribution partnerships with those seeking innovative solutions. We see EAACI as a key opportunity to build relationships that will drive future growth in the allergy and immunology space.
” Jason Smith, CEO, Bedfont® Related StoriesThe Bedfont® team is pleased to be joined by its Turkish distributor, Teknikel, to demonstrate its Fractional exhaled Nitric Oxide and hydrogen and methane breath testing technologies, highlighting how these innovative tools can support improved diagnosis, monitoring, and the management of respiratory and gastrointestinal conditions. The team will be at stand I03, where you can find the NObreath® FeNO device, which has been improving asthma care and management for over 15 years, providing an objective insight into airway inflammation, a key driver of asthma symptoms.
And the Gastrolyzer® range of HMBT devices, which have been aiding gastrointestinal investigation for over 35 years, enabling clinicians to tailor treatment effectively. For Bedfont®, this congress is invaluable not only for showcasing its solutions but also for engaging with partners and stakeholders as it continues to advance technology and expand its global reach. Source:Bedfont® Scientific Ltd.
Asthma Breath Analysis Healthcare Immunology Technology
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Thermo Fisher Scientific expands global biobank leadership through strategic collaboration with PRECISE-SG100K Singapore to advance population-scale proteomicsThermo Fisher Scientific Inc., the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region’s most ambitious and diverse population-scale biobank initiatives.
Read more »
ZTE Showcases AI Interactive Flat Panel at the Broadband User Congress in BrazilAI interactive flat panel aimed at offices, elder care, and classrooms with built-in conferencing, automation, and monitoring features unveiled
Read more »
ZTE hosts 2026 Broadband User Congress in São Paulo, under the Theme 'Monetize Your Intelligent Broadband'Empowering operators to move beyond basic connectivity with next-gen AI and ODN systems
Read more »
Congress investigates Canvas breach as company pays ransomInstructure CEO Steve Daly's got some explaining to do
Read more »